Nordic Capital, a private equity investor, completed the investment in Equashield, a provider of closed system transfer devices for hazardous drugs. Financial terms were not disclosed. "We are excited to partner with Nordic Capital. The cultural alignment between our two firms was a key driver behind our decision to invite Nordic Capital to join as a significant shareholder and support our continued growth," Eric Shem-Tov, Equashield CEO & Founder.